Free Trial

Venture Visionary Partners LLC Takes $1.60 Million Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Sabra Health Care REIT logo with Finance background

Venture Visionary Partners LLC bought a new stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 86,133 shares of the real estate investment trust's stock, valued at approximately $1,603,000.

A number of other large investors have also modified their holdings of SBRA. Vanguard Group Inc. raised its holdings in Sabra Health Care REIT by 2.5% in the 1st quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust's stock valued at $516,545,000 after buying an additional 838,654 shares during the period. Janus Henderson Group PLC grew its stake in shares of Sabra Health Care REIT by 2.9% during the first quarter. Janus Henderson Group PLC now owns 5,199,682 shares of the real estate investment trust's stock worth $76,701,000 after purchasing an additional 145,548 shares in the last quarter. LSV Asset Management grew its stake in shares of Sabra Health Care REIT by 2.5% during the second quarter. LSV Asset Management now owns 4,380,815 shares of the real estate investment trust's stock worth $67,465,000 after purchasing an additional 104,800 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Sabra Health Care REIT by 3.8% in the second quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust's stock valued at $52,275,000 after buying an additional 124,825 shares during the last quarter. Finally, APG Asset Management US Inc. raised its stake in Sabra Health Care REIT by 28.9% in the second quarter. APG Asset Management US Inc. now owns 2,562,962 shares of the real estate investment trust's stock valued at $39,495,000 after buying an additional 575,000 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Citigroup raised shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and increased their target price for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Scotiabank raised their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research note on Friday, October 11th. Truist Financial lifted their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. Finally, Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $18.38.

View Our Latest Stock Analysis on SBRA

Sabra Health Care REIT Trading Up 0.4 %

Shares of SBRA traded up $0.08 during mid-day trading on Tuesday, hitting $18.67. The company had a trading volume of 1,253,522 shares, compared to its average volume of 2,021,434. Sabra Health Care REIT, Inc. has a 1-year low of $12.83 and a 1-year high of $19.32. The business's 50-day simple moving average is $17.71 and its 200-day simple moving average is $15.88. The stock has a market cap of $4.37 billion, a PE ratio of 88.90, a P/E/G ratio of 2.68 and a beta of 1.26. The company has a quick ratio of 4.27, a current ratio of 4.27 and a debt-to-equity ratio of 0.89.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.24). The company had revenue of $176.14 million for the quarter, compared to analysts' expectations of $166.54 million. Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. The business's revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the prior year, the business earned $0.34 EPS. Sell-side analysts forecast that Sabra Health Care REIT, Inc. will post 1.38 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 19th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.43%. The ex-dividend date of this dividend was Monday, August 19th. Sabra Health Care REIT's payout ratio is currently 571.43%.

Sabra Health Care REIT Profile

(Free Report)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Further Reading

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

→ The most serious warning of my career (From Porter & Company) (Ad)

Should you invest $1,000 in Sabra Health Care REIT right now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines